In recent years, with the continuous innovation and transformation of the pharmaceutical industry, high-quality and efficient clinical trials have become one of the most important demands of the pharmaceutical industry at present. The drug clinical trial business is complicated and data volume is huge, putting forward higher requirements for drug supervision. Therefore, innovative regulatory methods and intelligent transformation are extremely in need. In order to meet various development requirements in the era of COVID-19, after years of exploration and practice, our province has started the construction of the supervision information system of drug clinical trial institutions in Hebei province, established a vertical supervision system from top to bottom, and realized the whole-process reengineering of the supervision of clinical trial institutions by means of information technology. We initiated the remote supervision mode of drug clinical trial institutions and explored the "on-site inspection-remote inspection" hybrid supervision and inspection mode. With the assistance of this system, the risk in the clinical trial process reduced, the personnel gathering under the COVID-19 epidemic reduced, while the efficiency of supervision and inspection is improved, the listing process of new and good drugs is accelerated, makingpeople easily access to good drugs as soon as possible.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |